5-(3-ethylsulfonylphenyl)-3-methyl-9H-pyrido[2,3-b]indole-7-carbaldehyde;methanamine
C22H23N3O3S — CID 143656881
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-(3-ethylsulfonylphenyl)-3-methyl-9H-pyrido[2,3-b]indole-7-carbaldehyde;methanamine
5-(3-ethylsulfonylphenyl)-3-methyl-9H-pyrido[2,3-b]indole-7-carbaldehyde;methanamine (PubChem CID 143656881) has the molecular formula C22H23N3O3S and a molecular weight of 409.51 g/mol. Its IUPAC name is 5-(3-ethylsulfonylphenyl)-3-methyl-9H-pyrido[2,3-b]indole-7-carbaldehyde;methanamine.
Molecular Properties
| Compound Name | 5-(3-ethylsulfonylphenyl)-3-methyl-9H-pyrido[2,3-b]indole-7-carbaldehyde;methanamine |
|---|---|
| PubChem CID | 143656881 |
| Molecular Formula | C22H23N3O3S |
| Molecular Weight | 409.51 g/mol |
| Exact Mass | 409.15 |
| IUPAC Name | 5-(3-ethylsulfonylphenyl)-3-methyl-9H-pyrido[2,3-b]indole-7-carbaldehyde;methanamine |
| SMILES | CCS(=O)(=O)c1cccc(-c2cc(C=O)cc3[nH]c4ncc(C)cc4c23)c1.CN |
| InChI | InChI=1S/C21H18N2O3S.CH5N/c1-3-27(25,26)16-6-4-5-15(10-16)17-8-14(12-24)9-19-20(17)18-7-13(2)11-22-21(18)23-19;1-2/h4-12H,3H2,1-2H3,(H,22,23);2H2,1H3 |
| InChIKey | XWHMZZBKYAXKJG-UHFFFAOYSA-N |
| XLogP | 3.87 |
| TPSA | 105.91 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 409.51 |
| LogP ≤ 5 | 3.87 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'aldehyde', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 143656881 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.